News

Filter

Current filters:

None

226 to 235 of 97840 results

Genticel licenses Vaxiclase platform to Serum Institute of India

04-02-2015

French biotech firm Genticel, a developer of therapeutic vaccines, has licensed its Vaxiclase technology…

BiotechnologyGenticelSerum Institute of IndiaVaxiclase

Amgen reports its biosimilar ABP 501 meets primary endpoint against adalimumab

Amgen reports its biosimilar ABP 501 meets primary endpoint against adalimumab

04-02-2015

USA-based biotech major Amgen has reported positive top-line data from a Phase III study of its biosimilar…

ABP 501adalimumabAmgenAnti-Arthritics/RheumaticsBiosimilarsHumiraResearchUSA

Roche announces positive Phase III results of Gazyva in non-Hodgkin's lymphoma

Roche announces positive Phase III results of Gazyva in non-Hodgkin's lymphoma

04-02-2015

Swiss drug major Roche has announced positive results from the Phase III study of Gazyva (obintuzumab)…

GazyvaOncologyPharmaceuticalResearchRoche

Novartis' Japan unit faces 15-day suspension over trial data manipulation

Novartis' Japan unit faces 15-day suspension over trial data manipulation

04-02-2015

The Japanese unit of Swiss drug major Novartis is facing suspension following allegations of data manipulation…

DiovanHematologyJapanLegalNovartis PharmaceuticalsOncologyPharmaceuticalRegulation

Isis Pharma stock falls after data from Phase II study of ISIS-PTP1B Rx

Isis Pharma stock falls after data from Phase II study of ISIS-PTP1B Rx

04-02-2015

US drugmaker Isis Pharmaceuticals has announced top-line results from a Phase II study of ISIS-PTP1BRx…

DiabetesIsis PharmaceuticalsPharmaceuticalResearchUSA

Generics will limit growth in French pharma market, says report

Generics will limit growth in French pharma market, says report

04-02-2015

The French pharmaceutical market is forecast to grow at a tepid compound annual growth rate (CAGR) of…

FranceGenericsMarkets & Marketing

Bleaker future for men with prostate cancer in England

04-02-2015

Today marks World Cancer Day, which this year focuses on “achieving treatment for all.” However,…

FinancialHealthcareJevtanaOncologyPharmaceuticalSanofiUK

Gilead beats 4th-qtr 2014 expectations, as hepatitis C drug sales soar

Gilead beats 4th-qtr 2014 expectations, as hepatitis C drug sales soar

04-02-2015

US biotech firm Gilead Sciences posted fourth-quarter and full-year financial results after markets closed…

Anti-viralsBiotechnologyFinancialGilead SciencesHarvoniSovaldi

Mallinckrodt's acquisitions pay off, as first quarter fiscal 2015 income doubles

Mallinckrodt's acquisitions pay off, as first quarter fiscal 2015 income doubles

03-02-2015

Ireland-based pharma company Mallinckrodt (NYSE: MNK) reported significantly higher income in the first…

ActharChemistryFinancialMallinckrodtOfirmev

226 to 235 of 97840 results

COMPANY SPOTLIGHT

Menarini

Back to top